title: Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?
authors.forename: Nitin
authors.initials: N
authors.lastname: Verma
authors.forename: Sandra M
authors.initials: SM
authors.lastname: Swain
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006333:Heart Failure / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D012307:Risk Factors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab